{"transactions":[{"id":4634426,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-10-03T00:16:51.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":39634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":39634,"derivative":{"exercise_price":1.18,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":39634},"source":{"system":"sec-edgar","filing":"0001878313-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000097/form4.xml","form_type":"4"}},{"id":718389,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-07-02T20:13:00.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":32630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":32630,"derivative":{"exercise_price":1.44,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":32630},"source":{"system":"sec-edgar","filing":"0001878313-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000072/form4.xml","form_type":"4"}},{"id":819909,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2026-04-02T20:53:36.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":33748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":33748,"derivative":{"exercise_price":1.4,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":33748},"source":{"system":"sec-edgar","filing":"0001878313-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000035/form4.xml","form_type":"4"}},{"id":951969,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Options","published_at":"2026-01-05T13:39:42.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":29789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":29789,"derivative":{"exercise_price":1.53,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":29789},"source":{"system":"sec-edgar","filing":"0001878313-26-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000012/form4.xml","form_type":"4"}},{"id":959780,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-12-23T13:14:35.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":81699,"price":1.36,"value":111110.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the six month anniversary of the issuance date and expire 3-years after the initial issuance date."}],"balance_after":81699,"derivative":{"exercise_price":1.36,"exercise_date":"2026-06-22","expiration_date":"2028-12-22","underlying":"Common Stock","underlying_shares":81699},"source":{"system":"sec-edgar","filing":"0001878313-25-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000069/form4.xml","form_type":"4"}},{"id":959779,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-23T13:14:35.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":81699,"price":1.224,"value":99999.576,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025"}],"balance_after":1248888,"source":{"system":"sec-edgar","filing":"0001878313-25-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000069/form4.xml","form_type":"4"}},{"id":1023447,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-10-06T20:24:44.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":25331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":25331,"derivative":{"exercise_price":1.8,"exercise_date":"2025-10-02","expiration_date":"2035-10-02","underlying":"Common Stock","underlying_shares":25331},"source":{"system":"sec-edgar","filing":"0001878313-25-000031","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831325000031/form4.xml","form_type":"4"}},{"id":1095576,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-07-02T20:16:10.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":25232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":25232,"derivative":{"exercise_price":1.8,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":25232},"source":{"system":"sec-edgar","filing":"0001127602-25-018655","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225018655/form4.xml","form_type":"4"}},{"id":1175726,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-04-08T20:44:14.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":26304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":26304,"derivative":{"exercise_price":1.5,"exercise_date":"2025-04-04","expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":26304},"source":{"system":"sec-edgar","filing":"0001127602-25-011813","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225011813/form4.xml","form_type":"4"}},{"id":1315327,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2025-01-03T21:11:50.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":15338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":15338,"derivative":{"exercise_price":1.98,"exercise_date":"2024-12-31","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":15338},"source":{"system":"sec-edgar","filing":"0001127602-25-000396","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225000396/form4.xml","form_type":"4"}},{"id":1394762,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-10-02T20:47:05.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":10848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date."}],"balance_after":10848,"derivative":{"exercise_price":2.81,"exercise_date":"2024-09-30","expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":10848},"source":{"system":"sec-edgar","filing":"0001127602-24-024938","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224024938/form4.xml","form_type":"4"}},{"id":1463433,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-07-02T20:10:18.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":8592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":8592,"derivative":{"exercise_price":3.42,"exercise_date":"2024-06-30","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":8592},"source":{"system":"sec-edgar","filing":"0001127602-24-019841","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224019841/form4.xml","form_type":"4"}},{"id":1534873,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-04-26T21:33:57.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":19665,"price":2.26,"value":44442.9,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024.  The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date."}],"balance_after":19665,"derivative":{"exercise_price":2.26,"exercise_date":"2024-10-25","expiration_date":"2029-10-25","underlying":"Common Stock","underlying_shares":19665},"source":{"system":"sec-edgar","filing":"0001127602-24-013490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224013490/form4.xml","form_type":"4"}},{"id":1534872,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-26T21:33:57.000Z","date":"2024-04-25","kind":"purchase","planned":false,"acquired":true,"shares":19665,"price":2.03,"value":39919.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024."}],"balance_after":1167189,"source":{"system":"sec-edgar","filing":"0001127602-24-013490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224013490/form4.xml","form_type":"4"}},{"id":1553964,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-04-02T20:59:55.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":13790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":13790,"derivative":{"exercise_price":2.2,"exercise_date":"2024-03-31","expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":13790},"source":{"system":"sec-edgar","filing":"0001127602-24-011895","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224011895/form4.xml","form_type":"4"}},{"id":1574976,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Warrants","published_at":"2024-03-15T23:09:40.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":170940,"price":1.3,"value":222222.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024.  The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date."}],"balance_after":170940,"derivative":{"exercise_price":1.3,"exercise_date":"2024-09-14","expiration_date":"2029-09-14","underlying":"Common Stock","underlying_shares":170940},"source":{"system":"sec-edgar","filing":"0001127602-24-010325","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224010325/form4.xml","form_type":"4"}},{"id":1574975,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-15T23:09:40.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":170940,"price":1.17,"value":199999.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024."}],"balance_after":1147524,"source":{"system":"sec-edgar","filing":"0001127602-24-010325","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224010325/form4.xml","form_type":"4"}},{"id":1693271,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2024-01-04T02:03:50.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":23127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":23127,"derivative":{"exercise_price":1.17,"exercise_date":"2023-12-31","expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":23127},"source":{"system":"sec-edgar","filing":"0001127602-24-000650","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224000650/form4.xml","form_type":"4"}},{"id":1767931,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-10-03T20:11:51.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":12567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":12567,"derivative":{"exercise_price":2.2,"exercise_date":"2023-09-30","expiration_date":"2033-09-30","underlying":"Common Stock","underlying_shares":12567},"source":{"system":"sec-edgar","filing":"0001127602-23-025154","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223025154/form4.xml","form_type":"4"}},{"id":1836812,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-07-05T12:16:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":13365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":13365,"derivative":{"exercise_price":2.2,"exercise_date":"2023-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":13365},"source":{"system":"sec-edgar","filing":"0001127602-23-019772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223019772/form4.xml","form_type":"4"}},{"id":1911462,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-28T10:49:10.000Z","date":"2023-04-27","kind":"purchase","planned":false,"acquired":true,"shares":48000,"price":2.25,"value":108000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023."}],"balance_after":976584,"source":{"system":"sec-edgar","filing":"0001127602-23-013710","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223013710/form4.xml","form_type":"4"}},{"id":1928962,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-04-04T10:32:17.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":8513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":8513,"derivative":{"exercise_price":3.46,"exercise_date":"2023-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":8513},"source":{"system":"sec-edgar","filing":"0001127602-23-012015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223012015/form4.xml","form_type":"4"}},{"id":2068597,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-01-04T23:18:12.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":4568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on December 30, 2022 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":4568,"derivative":{"exercise_price":3.51,"exercise_date":"2022-12-30","expiration_date":"2032-12-30","underlying":"Common Stock","underlying_shares":4568},"source":{"system":"sec-edgar","filing":"0001127602-23-000683","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223000683/form4.xml","form_type":"4"}},{"id":2197922,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":32978,"kind":"person","name":"Louie Ngar Yee","position":1,"cik":"0001913264","reported_name":"Louie Ngar Yee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T22:40:04.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022."}],"balance_after":928584,"source":{"system":"sec-edgar","filing":"0000899243-22-027461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027461/doc4.xml","form_type":"4"}}]}